Titel

Merkliste
1 Ergebnisse

Daratumumab plus lenalidomide and dexamethasone for untreat..:

Facon, T ; Kumar, Shaji ; Plesner, T...
Facon , T , Kumar , S , Plesner , T , Orlowski , R Z , Moreau , P , Bahlis , N , Basu , S , Nahi , H , Hulin , C , Quach , H , Goldschmidt , H , O'Dwyer , M , Perrot , A , Venner , C P , Weisel , K , Mace , J R , Raje , N , Attal , M , Tiab , M , Macro , M , Frenzel , L , Leleu , X , Ahmadi , T , Chiu , C , Wang , J , Rampelbergh , R V , Uhlar , C M , Kobos , R , Qi , M , Usmani , S Z , MAIA Trial Investigators & Abildgaard , N 2019 , ' Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma ' , New England Journal of Medicine , vol. 380 , no. 22 , pp. 2104-2115 . https://doi.org/10.1056/NEJMoa1817249. , 2019

Link: https://portal.findresearcher.sdu.dk/da/publications/c..

RT Journal
T1 <Title>Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsydanskunivpub:oai:sdu.dk:publications_c0aa869b-392f-4992-826b-d304d22e9023&Exemplar=1&LAN=DE
				
A1 Facon, T
A1 Kumar, Shaji
A1 Plesner, T
A1 Orlowski, R. Z
A1 Moreau, P
A1 Bahlis, N
A1 Basu, S
A1 Nahi, H
A1 Hulin, C
A1 Quach, H
A1 Goldschmidt, H
A1 O'Dwyer, M
A1 Perrot, A
A1 Venner, C. P
A1 Weisel, K
A1 Mace, J. R
A1 Raje, N
A1 Attal, M
A1 Tiab, M
A1 Macro, M
A1 Frenzel, L
A1 Leleu, X
A1 Ahmadi, T
A1 Chiu, C
A1 Wang, J
A1 Rampelbergh, R. Van
A1 Uhlar, C. M
A1 Kobos, R
A1 Qi, M
A1 Usmani, S. Z
A1 Abildgaard, Niels
YR 2019
K1 Aged
K1 80 and over
K1 Antibodies
K1 Monoclonal/administration & dosage
K1 Antineoplastic Combined Chemotherapy Protocols/adverse effects
K1 Dexamethasone/administration & dosage
K1 Female
K1 Humans
K1 Lenalidomide/administration & dosage
K1 Male
K1 Middle Aged
K1 Multiple Myeloma/drug therapy
K1 Neutropenia/chemically induced
K1 Progression-Free Survival
JF Facon , T , Kumar , S , Plesner , T , Orlowski , R Z , Moreau , P , Bahlis , N , Basu , S , Nahi , H , Hulin , C , Quach , H , Goldschmidt , H , O'Dwyer , M , Perrot , A , Venner , C P , Weisel , K , Mace , J R , Raje , N , Attal , M , Tiab , M , Macro , M , Frenzel , L , Leleu , X , Ahmadi , T , Chiu , C , Wang , J , Rampelbergh , R V , Uhlar , C M , Kobos , R , Qi , M , Usmani , S Z , MAIA Trial Investigators & Abildgaard , N 2019 , ' Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma ' , New England Journal of Medicine , vol. 380 , no. 22 , pp. 2104-2115 . https://doi.org/10.1056/NEJMoa1817249
LK http://dx.doi.org/https://portal.findresearcher.sdu.dk/da/publications/c0aa869b-392f-4992-826b-d304d22e9023
DO https://portal.findresearcher.sdu.dk/da/publications/c0aa869b-392f-4992-826b-d304d22e9023
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)